Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Jun 16, 2025; 17(6): 104539
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104539
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104539
Table 3 Histopathological and immunohistochemical analysis
Variable | Frequency (No.) | Percentage (%) |
Total | 14 | 100.0 |
Histopathology types | ||
Well differentiated tumor | 11 | 78.6 |
Grade 1 | 4 | 28.6 |
Grade 2 | 6 | 42.9 |
Grade 3 | 1 | 7.1 |
Poorly differentiated tumor | 3 | 21.4 |
Small cell | 2 | 14.3 |
Large cell | 1 | 7.1 |
Cytokeratin AE1/AE3 | ||
Positive | 13 | 92.9 |
Ki-67 | ||
Positive | 14 | 100.0 |
G1 (≤ 2%) | 3 | 21.4 |
G2 (3%-20%) | 8 | 57.2 |
G3 (> 20%) | 3 | 21.4 |
Synaptophysin | ||
Positive | 14 | 100.0 |
Chromogranin A | ||
Positive | 5 | 35.7 |
Negative | 1 | 7.1 |
Not done | 8 | 57.2 |
- Citation: Ayesha S, Karim MM, Shahid AH, Rehman AU, Uddin Z, Abid S. Diagnostic role of endoscopic ultrasonography in defining the clinical features and histopathological spectrum of gastroenteropancreatic neuroendocrine tumors. World J Gastrointest Endosc 2025; 17(6): 104539
- URL: https://www.wjgnet.com/1948-5190/full/v17/i6/104539.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i6.104539